Eko honored for achievements in AI-powered solutions to improve cardiac care BERKELEY, Calif.–(BUSINESS WIRE)–Eko today announced that it has been named to CB Insights’ fourth annual AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. “Eko has achieved numerous milestones over the past year, including partnerships with […]
Other News
Element Science Raises $145.6 million Series C Financing to Advance Next-Generation Digital Wearable Platform
Newcomers Deerfield, Qiming, Cormorant, and Invus join existing investors Third Rock and Google Ventures; Funding will enable Element Science to complete clinical studies, begin commercialization and develop a family of products SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular […]
BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial
REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced that Ralph Stephan von Bardeleben, MD, of the University Medical Center of Mainz […]
AliveCor Appoints Siva Somayajula as Chief Technology Officer
Former Amazon Director of Product Software and Services Brings Deep Expertise in Technology and Product Innovation MOUNTAIN VIEW, Calif., March 2, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer. For more than […]
Correvio Responds to Market Activity
VANCOUVER, March 2, 2020 /PRNewswire/ – At the request of Investment Industry Regulatory Organization of Canada (“IIROC”), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the “Company”) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level […]
Masimo Announces FDA Clearance of Continuous RRp® Monitoring
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today that continuous RRp® (respiration rate from the photoplethysmograph) monitoring of adult and pediatric patients with Rad-97®, Radical-7®, and Radius-7® Pulse CO-Oximeters® has received FDA clearance. With this clearance, both continuous and spot-check RRp are now available in the US, supported in a variety of pulse oximetry sensors […]
iRhythm Technologies Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Financial Outlook
SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Highlights — […]
CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis
ATLANTA, Feb. 27, 2020 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing resumed distribution in the European Union. The On-X AAP is indicated for the treatment of diseased, damaged or malfunctioning […]
LivaNova Receives FDA Clearance for 3T Heater-Cooler Device Modification
LONDON–(BUSINESS WIRE)–Feb. 25, 2020– LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for a device modification to its 3T Heater-Cooler® devices. The modification includes the installation of a 3T Aerosol Collection Set, as well as testing that demonstrates the effectiveness of […]
LivaNova Reports Fourth Quarter and Full-Year 2019 Results
LONDON–(BUSINESS WIRE)–Feb. 26, 2020– LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2019. For the fourth quarter of 2019, worldwide sales were $287.6 million, a decrease of 3.2 percent on a reported basis and a decrease of 2.2 percent on a […]



